Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

New ransomware threat with ties to Russia targets healthcare providers

The "prolific" ransomware group Clop is associated with Russia and has managed to breach some major healthcare systems.

Thumbnail

Regional One hit by data breach

Reventics, a revenue cycle management company and a business associate of Regional One Health, detected a cyber-intruder who accessed the company’s servers in December 2022.

CMS not changing ALZ drug restrictions

The announcement comes as more Alzheimer’s drugs are being evaluated with hopes that some new treatments could be breakthroughs.

Thumbnail

Cigna stops former executive from joining CVS Health

Cigna has blocked CVS Health from hiring Amy Bricker, a former Cigna executive, after a federal judge granted the company a temporary injunction.

 

More than 100 healthcare groups unite in support of prior authorization reform

The AMA and 118 other healthcare groups are urging CMS to finalize reforms that target prior authorization in Medicare Advantage plans that delay, deny and disrupt medically necessary care to patients.

Medicare money payment physician

More hospitals are complying with price transparency law

Even as progress is being made, some lawmakers want to increase penalties on hospitals that do not comply. 

Amazon

Amazon closes $3.9B acquisition of One Medical

The closure of the deal comes after Amazon faced some backlash toward the acquisition, with some arguing the move gives the retailer too much power.

Thumbnail

Millions unaware they will lose Medicaid coverage when COVID-19 PHE ends

In a survey by the Robert Wood Johnson Foundation from December 2022, 64.3% of adults in Medicaid-enrolled families were unaware of the resumption of Medicaid renewals in the future.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.